"Abbreviated" health claims would be allowed on labels with reference to full claim -- FDA.
This article was originally published in The Tan Sheet
Executive Summary
"ABBREVIATED" HEALTH CLAIMS ON PRINCIPAL DISPLAY PANEL WOULD BE ALLOWED as long as the claim "is accompanied by a prominent and adjacent reference to the full claim elsewhere on the label" and "is not misleading," FDA declared in a May 11 letter to the National Food Processors Association. FDA was responding to an October 1994 citizen petition filed by NFPA calling for the agency to modify its health claims regulations under the Nutrition Labeling & Education Act.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning